Radiocontrast Agent Market
Radiocontrast Agent Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Radiocontrast Agent Market Size and Growth
The Radiocontrast Agent market is witnessing significant growth due to increasing diagnostic imaging procedures. The global market size is projected to reach approximately USD 5 billion by 2025, driven by advancements in imaging technology and rising prevalence of chronic diseases, necessitating enhanced diagnostic capabilities and improved patient outcomes.
Companies Covered (Covid 19 Impact Covered)
◍ GE Healthcare (US)
◍ Bracco Imaging (Italy)
◍ Bayer HealthCare (Germany)
◍ Guerbet (France)
◍ Lantheus (US)
◍ Daiichi Sankyo (Japan)
◍ Unijules Life Sciences (India)
The radiocontrast agent market features major players like GE Healthcare, Bracco Imaging, and Bayer HealthCare, driving innovation and growth through advanced products. Companies focus on expanding applications and improving efficacy, fostering competitive strategies. Revenue highlights include GE Healthcare's $19 billion and Bayer HealthCare’s €4 billion in healthcare sales.
◍ J.B. Chemicals and Pharmaceuticals (India)
◍ Spago Nanomedicine (Sweden)
◍ Taejoon Pharm (South Korea)
◍ Jodas (India)
◍ Magnus Health (India)
Request Sample Report
Market Segmentation
By Application
◍ Interventional Radiology
◍ Interventional Cardiology
By Product
◍ Barium-based Radiocontrast Agent ◍ Iodinated Radiocontrast Agent
Gadolinium-based Radiocontrast Agent ◍ Microbubble Radiocontrast Agent ◍ Radiology
Market Growth
Request Sample Report
$ X Billion USD
